[View original text]
AIDOT has launched a machine learning-based cervical cancer artificial intelligence (AI) solution called 'Cerviray'.
Whenever AIDOT improves its self-developed AI algorithm, as a result of evaluating software (SW) quality through the Korea Information and Communication Technology Association (TTA), Cerviray has been recognized for its excellent quality with a sensitivity of 93% and specificity of 89%. Based on this result, Cerviray has obtained domestic GMP class 3
certification and to obtain KFDA class 3 certification accordingly, the clinical plan was officially received and the certification process was entered.
AIDOT has completed a mutual business cooperation contract with a domestic medical foundation. As soon as the Ministry of Food and Drug Safety certification is completed early
next year, it is planned to be applied immediately to primary hospitals that have expressed their intention to introduce it.
As a result of aggressive marketing in the global market, AIDOT has signed additional contracts in India and South America. In particular, it was selected for the 'Bio Health Worldwide Online 2020' program conducted by Seoul City and KOTRA, and achieved tangible results as a result of intensive conferences with partners from 17 countries.
In addition, joint research and additional main contracts were carried out due to high interest in Vietnamese national healthcare companies that have already entered through the
specialized overseas expansion program of the National IT Industry Promotion Agency (NIPA).
03rd. Dec. 2020. / Electronic Times / Reporter Ji-sun Kim
Comments can be added by Member only